2016
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors.
Thrombosis and haemostasis
PubMedResearch at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 80 publications
- Percutaneous Coronary Intervention , 43 publications
- Purinergic P2Y Receptor Antagonists , 42 publications
- Blood Platelets , 38 publications
Research activity
My publications
Filter publications
122 publications
2016
New oral anticoagulants and dual antiplatelet therapy: Focus on apixaban.
International journal of cardiology
PubMed • Publisher's site2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
Circulation
PubMed • Publisher's site2016
Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.
JACC. Cardiovascular interventions
PubMed • Publisher's site2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
Journal of the American College of Cardiology
PubMed • Publisher's site